South & Central America Organ Preservation Solutions Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type [University of Wisconsin Solution, Custodiol HTK, Perfadex, Hypothermosol, and Others], Application, Organ Type End User

The South & Central America organ preservation solutions market is expected to grow from US$ 19.58 Million in 2023 to US$ 27.37 Million by 2028. It is estimated to record a CAGR of 6.9% from 2023 to 2028.

Rising Prevalence of Cardiovascular Diseases (CVDs) Fuels South & Central America Organ Preservation Solutions Market Growth

CVDs are heart and blood vessel disorders, which include cerebrovascular diseases, coronary heart disease, rheumatic heart disease, and other diseases. Tobacco use, unhealthy diet, and physical inactivity increase the risk of heart attacks and strokes.

Cardiovascular diseases are becoming more and more prevalent worldwide. Cardiovascular diseases are the world's leading cause of death. Most CVD deaths are followed by a stroke and heart failure due to coronary heart disease (CHD). It is also stated that ~31% of all deaths are caused by cardiovascular diseases worldwide. According to organdonor.gov, the heart is the third-largest vital organ transplantation performed after kidney and liver. Besides, new technologies for a heart transplant will offer lucrative opportunities for the organ preservation solutions market. Technological innovation has been playing a critical role in increasing the widespread uptake of organ transplantation. For instance, the Transmedics Organ Care System (OCS) Heart, or"Heart in a Box," enables transplant doctors to travel to much farther locations in search of transplant hearts by acting as a miniature intensive care unit that maintains the heart's viability.

The increasing need for a heart transplant, owing to the rising prevalence of cardiovascular diseases, is expected to boost the market growth during the prediction period.

South & Central America Organ Preservation Solutions Market Overview

South and Central America consists of Brazil, Argentina, and the Rest of SAM. Brazil is expected to have the major market share in this region. Developing healthcare facilities, increasing incidence of hypertension, rising geriatric population, and increasing incidence of kidney and heart diseases are expected to fuel the organ preservation solutions market growth.

The prevalence of hypertension has been linked to the aging population in Brazil. Estimates from the Brazilian Institute of Geography and Statistics (IBGE) indicate that, by 2060, people over 65 years old will account for 25.5% of the population. The rising geriatric population is expected to result in a high prevalence of kidney failure. The majority of the CKD burden is met by low- and middle-income countries. Sepsis is the leading cause of death in intensive care units in Brazil. Many studies have revealed that the incidence of the disease is growing over time, and there is only a slight reduction in mortality. The Sepsis Prevalence Assessment Database Project (SPREAD), a statewide 1-day point prevalence survey of Brazilian intensive care units (ICUs), found a sepsis incidence of 36.3 cases per 1,000 patient days and a shocking hospital mortality rate of 55.7%.

South & Central America Organ Preservation Solution Market Revenue and Forecast to 2028 (US$ Million)

South & Central America Organ Preservation Solution Market Segmentation

The South & Central America organ preservation solution market is segmented into type, application, organ type, end user, and country.

Based on type, the South & Central America organ preservation solution market is segmented into University of Wisconsin solution, custodiol htk, perfadex, hypothermosol, and others. The University of Wisconsin solution segment registered the largest South & Central America organ preservation solution market share in 2023.

Based on application, the South & Central America organ preservation solution market is segmented into static cold storage, hypothermic machine perfusion, normothermic machine perfusion, and others. The static cold storage segment held the largest South & Central America organ preservation solution market share in 2023.

Based on organ type, the South & Central America organ preservation solutions market is segmented into kidneys, liver, lungs, heart, and others. The kidney segment held the largest South & Central America organ preservation solution market share in 2023.

Based on end user, the South & Central America organ preservation solutions market is segmented into organ transplant centers, hospitals, and specialty clinics. The organ transplant centers segment held the largest South & Central America organ preservation solution market share in 2023.

Based on country, the South & Central America organ preservation solutions market has been categorized into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America organ preservation solutions market share in 2023.

Accord Healthcare; Dr. Franz Koehler Chemie GmbH; Lifeline Scientific, Inc; and TransMedics are the leading companies operating in the South & Central America organ preservation solutions market in the region.

Reasons to Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America organ preservation solution market.
• Highlights key business priorities in order to assist companies to realign their business strategies
• The key findings and recommendations highlight crucial progressive industry trends in the South & Central America organ preservation solution market, thereby allowing players across the value chain to develop effective long-term strategies
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
• Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the organ preservation solution market as well as those hindering it
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution